Renal hemodialysis and maternal serum triple analyte screening

Lee P. Shulman, Rodney Briggs, Owen Phillips, Steven A. Friedman, Baha Sibai

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The obstetrical management of women with renal disease is complicated and associated with increased fetal and maternal morbidity. However, maternal serum screening is an integral part of obstetrical care and should be offered to all women. We found that maternal serum levels of α-fetoprotein and human chorionic gonadotropin did not significantly change as a result of hemodialysis, whereas levels of unconjugated estriol were markedly decreased following hemodialysis. Maternal serum screening should be limited to α-fetoprotein analysis in women undergoing hemodialysis until the effects of hemodialysis on all serum analytes are better delineated.

Original languageEnglish (US)
Pages (from-to)26-28
Number of pages3
JournalFetal Diagnosis and Therapy
Volume13
Issue number1
DOIs
StatePublished - Apr 28 1998

Fingerprint

Renal Dialysis
Mothers
Fetal Proteins
Kidney
Serum
Estriol
Chorionic Gonadotropin
Morbidity

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Renal hemodialysis and maternal serum triple analyte screening. / Shulman, Lee P.; Briggs, Rodney; Phillips, Owen; Friedman, Steven A.; Sibai, Baha.

In: Fetal Diagnosis and Therapy, Vol. 13, No. 1, 28.04.1998, p. 26-28.

Research output: Contribution to journalArticle

Shulman, Lee P. ; Briggs, Rodney ; Phillips, Owen ; Friedman, Steven A. ; Sibai, Baha. / Renal hemodialysis and maternal serum triple analyte screening. In: Fetal Diagnosis and Therapy. 1998 ; Vol. 13, No. 1. pp. 26-28.
@article{2eb6eda90a9f4e5bbafee8d2cc7ca215,
title = "Renal hemodialysis and maternal serum triple analyte screening",
abstract = "The obstetrical management of women with renal disease is complicated and associated with increased fetal and maternal morbidity. However, maternal serum screening is an integral part of obstetrical care and should be offered to all women. We found that maternal serum levels of α-fetoprotein and human chorionic gonadotropin did not significantly change as a result of hemodialysis, whereas levels of unconjugated estriol were markedly decreased following hemodialysis. Maternal serum screening should be limited to α-fetoprotein analysis in women undergoing hemodialysis until the effects of hemodialysis on all serum analytes are better delineated.",
author = "Shulman, {Lee P.} and Rodney Briggs and Owen Phillips and Friedman, {Steven A.} and Baha Sibai",
year = "1998",
month = "4",
day = "28",
doi = "10.1159/000020796",
language = "English (US)",
volume = "13",
pages = "26--28",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Renal hemodialysis and maternal serum triple analyte screening

AU - Shulman, Lee P.

AU - Briggs, Rodney

AU - Phillips, Owen

AU - Friedman, Steven A.

AU - Sibai, Baha

PY - 1998/4/28

Y1 - 1998/4/28

N2 - The obstetrical management of women with renal disease is complicated and associated with increased fetal and maternal morbidity. However, maternal serum screening is an integral part of obstetrical care and should be offered to all women. We found that maternal serum levels of α-fetoprotein and human chorionic gonadotropin did not significantly change as a result of hemodialysis, whereas levels of unconjugated estriol were markedly decreased following hemodialysis. Maternal serum screening should be limited to α-fetoprotein analysis in women undergoing hemodialysis until the effects of hemodialysis on all serum analytes are better delineated.

AB - The obstetrical management of women with renal disease is complicated and associated with increased fetal and maternal morbidity. However, maternal serum screening is an integral part of obstetrical care and should be offered to all women. We found that maternal serum levels of α-fetoprotein and human chorionic gonadotropin did not significantly change as a result of hemodialysis, whereas levels of unconjugated estriol were markedly decreased following hemodialysis. Maternal serum screening should be limited to α-fetoprotein analysis in women undergoing hemodialysis until the effects of hemodialysis on all serum analytes are better delineated.

UR - http://www.scopus.com/inward/record.url?scp=0031896401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031896401&partnerID=8YFLogxK

U2 - 10.1159/000020796

DO - 10.1159/000020796

M3 - Article

VL - 13

SP - 26

EP - 28

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 1

ER -